CXCL12-targeted immunomodulatory gene therapy reduces radiation-induced fibrosis in healthy tissues.
Paget JT, Ward JA, McKean AR, Mansfield DC, McLaughlin M, Kyula-Currie JN, Smith HG, Roulstone V, Li C, Zhou Y, Hardiman T, Grigoriadis A, O'Brien Coon D, Irshad S, Melcher AA, Harrington KJ, Khan A.
Paget JT, et al. Among authors: o brien coon d.
Mol Cancer Ther. 2024 Dec 12. doi: 10.1158/1535-7163.MCT-23-0872. Online ahead of print.
Mol Cancer Ther. 2024.
PMID: 39666014